Compass Therapeutics, Inc.Compass Therapeutics, Inc.Compass Therapeutics, Inc.

Compass Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪202.26 M‬USD
−0.33USD
‪−42.49 M‬USD
‪86.21 M‬
Beta (1Y)
0.97

About Compass Therapeutics, Inc.

CEO
Vered Bisker-Leib
Headquarters
Boston
Employees (FY)
32
Founded
2014
ISIN
US20454B1044
FIGI
BBG00LPXKF25
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CMPX is 1.47 USD — it has decreased by 1.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Compass Therapeutics, Inc. stocks are traded under the ticker CMPX.
Compass Therapeutics, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
CMPX stock is 12.25% volatile and has beta coefficient of 0.97. Check out the list of the most volatile stocks — is Compass Therapeutics, Inc. there?
One year price forecast for Compass Therapeutics, Inc. has a max estimate of 11.00 USD and a min estimate of 8.00 USD.
CMPX earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.11 USD resulting in a 25.33% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Compass Therapeutics, Inc. earnings.
Yes, you can track Compass Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CMPX stock has fallen by 8.13% compared to the previous week, the month change is a 30.66% fall, over the last year Compass Therapeutics, Inc. has showed a 51.00% decrease.
CMPX net income for the last quarter is ‪−13.42 M‬ USD, while the quarter before that showed ‪−9.96 M‬ USD of net income which accounts for −34.63% change. Track more Compass Therapeutics, Inc. financial stats to get the full picture.
Today Compass Therapeutics, Inc. has the market capitalization of ‪202.26 M‬, it has decreased by 5.56% over the last week.
No, CMPX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Compass Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CMPX reached its all-time high on Apr 16, 2021 with the price of 11.00 USD, and its all-time low was 1.15 USD and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 32.00 employees. See our rating of the largest employees — is Compass Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Compass Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Compass Therapeutics, Inc. stock shows the strong sell signal. See more of Compass Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Compass Therapeutics, Inc. future price: according to them, CMPX price has a max estimate of 11.00 USD and a min estimate of 8.00 USD. Read a more detailed Compass Therapeutics, Inc. forecast: see what analysts think of Compass Therapeutics, Inc. and suggest that you do with its stocks.